- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00594893
Study Comparing Mini-Incision Versus 2-Incision Approach for Total Hip Replacement
A Prospective Randomized Trial of Mini Incision and 2-Incision Total Hip Arthroplasty
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Recently, surgical techniques and surgical instruments have been developed to limit the dissection required to perform a total hip arthroplasty. Proponents of these procedures feel that it is associated with less perioperative blood loss, less pain and an accelerated recovery while critics have raised concerns that the more limited exposure may negatively impact component position and increase the risk of perioperative complications. Among less invasive surgical techniques, two of the different approaches utilized include a "mini-incision" posterior approach which aims to limit the amount of dissection associated with a standard posterior approach to the hip and a 2-incision technique which seeks to further limit soft tissue disruption by taking advantage of intermuscular planes and the use of fluoroscopic guidance.
While the mini-posterior approach utilizes an abbreviated exposure which is familiar to most surgeons, the 2-incision approach is a more novel approach and critics of this approach feel that its technically demanding nature may be associated with a higher risk of complications and component malposition. Proponents of the 2-incision approach feel that this approach is less invasive, more muscle sparing and leads to substantial improvements in patient rehabilitation and recovery with potential longer-term benefits in terms of improved function. The goal of this project is to compare the use of a mini-incision posterior approach and the 2-incision approach in primary total hip arthroplasty via a prospective randomized trial.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- Rush University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- diagnosis of hip osteoarthritis
- age greater than 18 years
- willingness to undergo a neuraxial anesthetic for the procedure
- female patient greater than one year postmenopausal, surgically sterile or using an accepted form of contraception
Exclusion Criteria:
- use of any medication that may impact platelet aggregation within 10 days of surgery
- chronic use of coumadin for anticoagulation
- the use of low molecular weight heparin postoperatively
- clinically significant systemic disease or laboratory abnormalities
- a primary hematologic disorder
- recent gastrointestinal or intracranial bleeding
- any contraindication to anticoagulant use
- history of previous ipsilateral hip surgery
- a body mass index of greater than 30
- significant hip deformity that precludes the use of standard implants
- use of ONLY general anesthetic during surgery
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: 1
Mini Incision Approach
|
Mini Incision Approach
|
|
Active Comparator: 2
2 Incision Approach
|
2 Incision Approach
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Pain scores
Time Frame: Daily for 6 weeks postoperatively
|
Daily for 6 weeks postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Functional milestones
Time Frame: daily for 6 weeks postoperatively
|
daily for 6 weeks postoperatively
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Craig J DellaValle, MD, Rush University Medical Center, Department of Orthopaedics
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CDV-05061503
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.